FDA Approved: DAYVIGO — Original Application (Eisai Inc.)

View source ↗

Summary

FDA approved DAYVIGO (lemborexant) from Eisai as the original application for adults with insomnia, marking the drug's initial regulatory authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Dayvigo (lemborexant)

Snippet

ORIG AP for DAYVIGO (LEMBOREXANT)